Rapid quantitation of (−)-2′-deoxy-3′-thiacytidine in human serum by high-performance liquid chromatography with ultraviolet detection

This publication has 14 references indexed in Scilit:

• Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter
  New England Journal of Medicine, 1995
• A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
  New England Journal of Medicine, 1995
• Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
  The Journal of Infectious Diseases, 1995
• Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients
  The Lancet, 1995
• Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.
  Journal of Clinical Investigation, 1995
• Interspecies Scaling and Pharmacokinetic Parameters of 3TC in Humans
  The Journal of Clinical Pharmacology, 1994
• Pharmacokinetics of 3TC (GR109714X) Administered With and Without Food to HIV-infected Patients
  Clinical Drug Investigation, 1993
• Comparison of cytotoxicity of the (−)- and (+)- enantiomer of 2′,3′- dideoxy-3′-thiacytidine in normal human bone marrow progenitor cells
  Biochemical Pharmacology, 1992
• Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.
  Published by Elsevier ,1992
• The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro
  Antimicrobial Agents and Chemotherapy, 1992